Here, we sought to systematically investigate the effects of the PD causal Lrrk2 G2019S mutation in the mouse endogenous genome (G2019S knock-in mice) at steady state and in the early response to intestinal infection. This evidence concerns the gene LRRK2 and Parkinson disease.